Abstract Title: Efficacy from the phase 1 study of FID-007, a novel nanoparticle paclitaxel formulation, in patients with head and neck squamous cell carcinoma

Session: Head and Neck Cancer

Presentation Date and Time: June 2, 2024, from 9:00 a.m. to 12:00 p.m. Central Time

Presentation Type: Poster Session

Abstract #6042, Poster Board #345

Title: Critical clinical evaluation of plasma to tumor tissue concordance by cancer type using Illumina’s cell-free ctTSO500 commercial liquid biopsy assay

Abstract/Poster #: 222-B

Title: FID-007: Nanoencapsulated Paclitaxel Derived from a Novel Nano-Drug Delivery Platform

Abstract/Poster #: 782-B

Title: A phase 1 dose escalation/expansion study of FID-007, a novel nanoparticle paclitaxel formulation, in patients with solid tumors

Presenters: Drs. Jacob Thomas and Anthony El-Khoueiry of University of Southern California